Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Apomorphine Infusion in Parkinson's Disease
NCT04887467Phase 4Completed
- Sponsor
- CHU Rennes
- Start
- Sep 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apomorphine in Parkinson's disease (PD), sponsored by CHU Rennes. Started Sep 2021; status: completed.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04887467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04887467.